Orion
54,3
EUR
+1,4 %
13.982 følger denne virksomhed
ORNBV
NASDAQ Helsinki
Biotechnology & Pharmaceuticals
Health Care
Overview
Finansielt overblik og estimater
Investor consensus
+1,4%
-4,5%
+6,97%
+26,93%
+16,22%
+64,05%
+33,38%
+15,04%
+383,53%
Orion operates in the pharmaceutical industry. The company conducts research and development of human and veterinary drugs, where the main focus is on diseases that affect the nervous system, as well as oncology and respiratory diseases. Today, the company's products are found on a global level, with the largest presence in the Nordic region and the rest of Europe. The company's head office is located in Espoo, Finland.
Læs mereMarkedsværdi
7,66 mia. EUR
Aktieomsætning
9,3 mio. EUR
P/E (adj.) (25e)
23,27
EV/EBIT (adj.) (25e)
18,28
P/B (25e)
6,93
EV/S (25e)
4,73
Udbytteafkast, % (25e)
3,13 %
Omsætning og EBIT-margin
Omsætning mia.
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
18.7
2025
Delårsrapport Q2'25
15.10
2025
Halvårligt udbytte
28.10
2025
Delårsrapport Q3'25
Risiko
Business risk
Valuation risk
Lav
Høj
Alle
Analyse
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Orion and Criceto Announce a License Agreement for APORON®, an Innovative Apomorphine Spray to Treat OFF Episodes in Parkinson’s Disease
Composition of the Nomination Committee of Orion Corporation
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
